» Articles » PMID: 22562054

Size-dependent Induction of Accelerated Blood Clearance Phenomenon by Repeated Injections of Polymeric Micelles

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2012 May 8
PMID 22562054
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

An accelerated blood clearance (ABC) phenomenon is induced by repeated injections of poly(ethylene glycol)-modified (PEGylated) liposomes. We previously indicated that the phenomenon was induced by polymeric micelles possessing PEG chains like as liposomes, although, the induction mechanism of the ABC phenomenon is not fully elucidated. In the present study, we investigate whether repeat-injection of the polymeric micelles having PEG chains trigger the phenomenon or not. Two polymeric micelles, PM-30 (polymeric micelles with 33.6nm in diameter) and PM-75 (76.2nm), were prepared with PEG-poly[Asp(pentyl)] and PEG-poly[Asp(nonyl)], respectively. We firstly examined the ABC-triggering effect of these micelles, and observed that both polymeric micelles, especially PM-75, induced the production of anti-PEG IgM antibody in treated mice. Then, PM-30 or PM-75 was preadministered into mice as a preconditioning. Seven days later, AlexaFluor594-labeled PM-30 or PM-75 was administered to determine the susceptibility of the phenomenon. As a result, rapid clearance of AlexaFluor594-labeled PM-75 from the bloodstream and accumulation in the liver were observed in PM-75 pretreated mice. Although, the ABC phenomenon of AlexaFluor594-labeled PM-30 was less obvious in PM-30 pretreated mice. Our present results indicated that the repeated injections of polymeric micelles caused the ABC phenomenon in a size-dependent manner.

Citing Articles

Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems.

Pan J, Wang Y, Chen Y, Zhang C, Deng H, Lu J J Nanobiotechnology. 2025; 23(1):138.

PMID: 40001108 PMC: 11853785. DOI: 10.1186/s12951-025-03209-0.


Effect of Anti-PEG Antibody on Immune Response of mRNA-Loaded Lipid Nanoparticles.

Omata D, Kawahara E, Munakata L, Tanaka H, Akita H, Yoshioka Y Mol Pharm. 2024; 21(11):5672-5680.

PMID: 39324825 PMC: 11539066. DOI: 10.1021/acs.molpharmaceut.4c00628.


PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives.

Kong Y, Dreaden E Front Bioeng Biotechnol. 2022; 10:879988.

PMID: 35573237 PMC: 9092184. DOI: 10.3389/fbioe.2022.879988.


Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications.

Cao Y, Dong X, Chen X Pharmaceutics. 2022; 14(4).

PMID: 35456613 PMC: 9026371. DOI: 10.3390/pharmaceutics14040778.


Injectables and Depots to Prolong Drug Action of Proteins and Peptides.

Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw P, Williams G Pharmaceutics. 2020; 12(10).

PMID: 33096803 PMC: 7589296. DOI: 10.3390/pharmaceutics12100999.